학술논문

Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism
Document Type
Article
Author
Madridano, Olgadel Toro, JorgeLorenzo, AliciaMartín, MarGómez Cerezo, JorgeHernández, LuisPrandoni, PaoloMonreal, ManuelArcelus, J.I.Arroyo, M.Ballaz, A.Barba, R.Barrón, M.Barrón-Andrés, B.Bascuñana, J.Bedate, P.Blanco-Molina, A.Bueso, T.Casado, I.del Molino, F.del Toro, J.Falgá, C.Fernández-Capitán, C.Font, C.Fuentes, M.I.Gallego, P.García-Bragado, F.Gavín, O.Gómez, V.González, J.González-Bachs, E.Grau, E.Guil, M.Guijarro, R.Gutiérrez, J.Hernández, L.Hernández-Huerta, S.Jara-Palomares, L.Jaras, M.J.Jiménez, D.Lecumberri, R.Lobo, J.L.López-Jiménez, L.López-Sáez, J.B.Lorente, M.A.Lorenzo, A.Luque, J.M.Madridano, O.Macià, M.Maestre, A.Marchena, P.J.Martín, M.Martín-Villasclaras, J.J.Monreal, M.Mora, J.M.Mosquera, D.Muñoz, F.J.Nauffal, M.D.Nieto, J.A.Núñez, M.J.Ogea, J.L.Otero, R.Pedrajas, J.M.Peris, M.L.Riera-Mestre, A.Rivas, A.Rodríguez-Dávila, M.A.Román, P.Rosa, V.Ruiz, J.Ruiz-Gamietea, A.Ruiz-Giménez, N.Sahuquillo, J.C.Samperiz, A.Sánchez Muñoz-Torrero, J.F.Soler, S.Suriñach, J.M.Tiberio, G.Tilvan, R.M.Tolosa, C.Trujillo, J.Uresandi, F.Valdés, M.Valero, B.Valle, R.Vela, J.Vidal, G.Vilar, C.Villalobos, A.Villalta, J.Malý, R.Hirmerova, J.Miklo sová, M.Salgado, E.Bertoletti, L.Bura-Riviere, A.Farge-Bancel, D.Mahe, I.Merah, A.Quere, I.Schellong, S.Babalis, D.Papadakis, M.Tzinieris, I.Braester, A.Brenner, B.Tzoran, I.Zeltser, D.Barillari, G.Ciammaichella, M.Di Micco, P.Duce, R.Maida, R.Dalla Valle, F.Piovella, C.Poggio, R.Prandoni, P.Quintavalla, R.Rota, L.Schenone, A.Tiraferri, E.Tonello, D.Tufano, A.Visonà, A.Zalunardo, B.Fernandes, M.Gonçalves, F.Santos, M.Saraiva, M.Sousa, R.Bosevski, M.Kovacevic, D.Alatri, A.Aujeski, D.Bounameaux, H.Calanca, L.Mazzolai, L.
Source
Journal of Vascular Surgery: Venous and Lymphatic Disorders; April 2015, Vol. 3 Issue: 2 p135-141.e1
Subject
Language
ISSN
2213333X
Abstract
Patients with acute venous thromboembolism (VTE) are at increased risk for the development of subsequent arterial ischemic events unrelated to the diagnosis of VTE. Accurate identification of VTE patients at increased risk for ischemic events during the course of anticoagulation may help to select those who would potentially benefit from concomitant therapy with anticoagulants and antiplatelets.